Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by NeoGenomics, Inc.

< Previous 1 2 Next >
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference
From NeoGenomics, Inc.
Via Business Wire
Tickers NEO
NeoGenomics Reports Fourth Quarter and Full Year 2023 Results
From NeoGenomics, Inc.
Via Business Wire
Tickers NEO
NeoGenomics Signs Working with Cancer Pledge in Support of Employees
From NeoGenomics, Inc.
Via Business Wire
Tickers NEO
NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024
From NeoGenomics, Inc.
Via Business Wire
Tickers NEO
NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
From NeoGenomics, Inc.
Via Business Wire
Tickers NEO
NeoGenomics Announces Chief Executive Officer Appointment
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics Schedules its Second Quarter 2022 Earnings Release for August 9, 2022
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics Liquid Biopsy Subsidiary Inivata Announces New Data Demonstrating Clinical Potential of the RaDaR(TM) MRD Test in HR+ HER2- Breast Cancer
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics To Participate In Multiple Upcoming Institutional Investor Conferences
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics Receives CAP Certification in their Suzhou China Pharma Services Laboratory
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics Appoints Lynn Tetrault Interim CEO
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics Liquid Biopsy Subsidiary Inivata and Collaborators Present New Data Further Validating the Application of its RaDaR(R) MRD and InVisionFirst(R)-Lung Tests at the 2022 ASCO Annual Meeting
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics To Participate in the BofA Securities 2022 Healthcare Conference
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics Reports Revenue of $117 Million in the First Quarter
From NeoGenomics, Inc.
Via AccessWire
Exposures COVID-19
Tickers NEO
NeoGenomics Inc. Announces Partnership with Lilly for Lung Cancer Sponsored Testing Program Utilizing the NeoTYPE(R) DNA and RNA Assay
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR(TM) Assay MRD Assay at AACR 2022
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics, Inc. Expands Its Global Strategic Partnership Initiatives with Biognosys AG on Multiple Next Generation Proteomics Solutions Supporting Biopharma R&D
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics Schedules its First Quarter 2022 Earnings Release for April 27, 2022
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics Announces CEO Departure and Initiates CEO Search
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR(TM) Assay in Non-Small Cell Lung Cancer
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics To Participate In Multiple Upcoming Institutional Investor Conferences
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics Reports Full Year Revenue of $484 Million and $126 Million for the Fourth Quarter of 2021
From NeoGenomics, Inc.
Via AccessWire
Exposures COVID-19
Tickers NEO
NeoGenomics appoints Dr. Shashi Kulkarni, a World-Renowned Oncology Genomics Expert, and Innovator as Chief Scientific Officer
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics Liquid Biopsy Subsidiary Inivata and Collaborators Publish Positive Results from Prospective Clinical Study of RaDaR(TM) in Head and Neck Squamous Cell Carcinoma
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics to Participate Virtually in Multiple Upcoming Institutional Investor Conferences
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics Schedules its Fourth Quarter and Full Year 2021 Earnings Release for February 23, 2022
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics First to Partner with Biomarker Collaborative and Deliver Patient Resources Along with Oncology Testing Results
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics Announces RaDaR(TM) Assay Receives CE Mark and is Submitted for US Reimbursement via the MolDX Program
From NeoGenomics, Inc.
Via AccessWire
Tickers NEO
NeoGenomics Appoints David Eberhard MD, PhD as Chief Medical Officer of Inivata Liquid Biopsy Subsidiary
From NeoGenomics, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures COVID-19 Legal Product Safety
Tickers NEO
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.